[{"address1": "302 East Pettigrew St.", "address2": "Suite A-100", "city": "Durham", "state": "NC", "zip": "27701", "country": "United States", "phone": "919 314 5512", "fax": "480 393 5553", "website": "https://precisionbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 102, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael  Amoroso", "age": 46, "title": "President, CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1094351, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jefferson J. Smith Ph.D.", "age": 51, "title": "Co-Founder & Chief Research Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 640195, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Alexander Kelly R.Ph.", "age": 57, "title": "CFO & Principal Accounting Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 671382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cassie  Gorsuch Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naresh  Tanna", "title": "Chief of Staff to CEO & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dario  Scimeca J.D.", "age": 49, "title": "General Counsel & Secretary", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 576432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Juli  Blanche", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy  Atwell", "title": "Chief Development & Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Leatherbury M.S.", "title": "Senior VP and Head of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.42, "open": 5.44, "dayLow": 5.3645, "dayHigh": 5.45, "regularMarketPreviousClose": 5.42, "regularMarketOpen": 5.44, "regularMarketDayLow": 5.3645, "regularMarketDayHigh": 5.45, "payoutRatio": 0.0, "beta": 1.714, "forwardPE": -0.8023599, "volume": 85312, "regularMarketVolume": 85312, "averageVolume": 128060, "averageVolume10days": 95170, "averageDailyVolume10Day": 95170, "bid": 5.35, "ask": 5.5, "bidSize": 1, "askSize": 1, "marketCap": 64121232, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 9.549, "allTimeHigh": 710.1, "allTimeLow": 3.61, "priceToSalesTrailing12Months": 50.84951, "fiftyDayAverage": 4.8974, "twoHundredDayAverage": 4.91635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 31324232, "profitMargins": 0.0, "floatShares": 10550771, "sharesOutstanding": 11786991, "sharesShort": 1157753, "sharesShortPriorMonth": 1220193, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.09819999, "heldPercentInsiders": 0.11319, "heldPercentInstitutions": 0.4422, "shortRatio": 14.99, "shortPercentOfFloat": 0.1012, "impliedSharesOutstanding": 11786991, "bookValue": 2.926, "priceToBook": 1.8591933, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -78255000, "trailingEps": -10.15, "forwardEps": -6.78, "lastSplitFactor": "1:30", "lastSplitDate": 1707868800, "enterpriseToRevenue": 24.841, "enterpriseToEbitda": -0.355, "52WeekChange": -0.41125542, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 5.44, "targetHighPrice": 60.0, "targetLowPrice": 19.0, "targetMeanPrice": 36.33333, "targetMedianPrice": 30.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 62242000, "totalCashPerShare": 5.281, "ebitda": -88168000, "totalDebt": 29445000, "quickRatio": 4.587, "currentRatio": 5.178, "totalRevenue": 1261000, "debtToEquity": 86.466, "revenuePerShare": 0.141, "returnOnAssets": -0.41, "returnOnEquity": -1.43893, "grossProfits": 1261000, "freeCashflow": -26599750, "operatingCashflow": -63918000, "revenueGrowth": -1.0, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1215.3889, "financialCurrency": "USD", "symbol": "DTIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1553779800000, "postMarketChangePercent": 1.1047808, "postMarketPrice": 5.5001, "postMarketChange": 0.06010008, "regularMarketChange": 0.02, "regularMarketDayRange": "5.3645 - 5.45", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 128060, "fiftyTwoWeekLowChange": 1.8300002, "fiftyTwoWeekLowChangePercent": 0.5069253, "fiftyTwoWeekRange": "3.61 - 9.549", "fiftyTwoWeekHighChange": -4.1089997, "fiftyTwoWeekHighChangePercent": -0.43030682, "fiftyTwoWeekChangePercent": -41.12554, "longName": "Precision BioSciences, Inc.", "regularMarketChangePercent": 0.369003, "regularMarketPrice": 5.44, "corporateActions": [], "postMarketTime": 1759534520, "regularMarketTime": 1759521601, "exchange": "NCM", "messageBoardId": "finmb_41018856", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "earningsTimestamp": 1754539200, "earningsTimestampStart": 1762864200, "earningsTimestampEnd": 1762864200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.15, "epsForward": -6.78, "epsCurrentYear": -7.9, "priceEpsCurrentYear": -0.6886076, "fiftyDayAverageChange": 0.54260015, "fiftyDayAverageChangePercent": 0.110793516, "twoHundredDayAverageChange": 0.52365017, "twoHundredDayAverageChangePercent": 0.10651198, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "shortName": "Precision BioSciences, Inc.", "displayName": "Precision BioSciences", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]